http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021195300-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff81a650b70e913d3b2524b45e4c7320
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed28726de9f916f355f8adc331e736b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
filingDate 2021-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f140113f4482c549bd2e056ce8c5f421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5213e399a4a8eeac83d3b1824d4927f2
publicationDate 2021-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021195300-A1
titleOfInvention Inhaled interferons for viral respiratory infections
abstract Aerosolized interferon-γ is disclosed for use in preventing or treating a respiratory viral infection or pneumonia caused by a viral infection. The interferon-γ is formulated in an aqueous solution at a concentration of about 0.05 to 2.5 mg of biologically active protein per mL of solution. In an embodiment, a 2.0 mL solution containing 400 µg of interferon-γ1b is administered as an aerosol produced by a breath-enhanced jet nebulizer that can produce the aerosol with a mass median aerodynamic diameter (MMAD) of about 1.0 microns. This treatment may be effective to prevent, treat, or limit the severity of the course of infection for COVID-19, influenza, and other clinically significant viral infections.
priorityDate 2020-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016250142-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005201982-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012219523-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011000480-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406840
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9899050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226069
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251

Total number of triples: 31.